Ullman Anders
SEC insider (Form 3/4/5 filer). CIK 0001836816. Director at Verona Pharma plc (VRNA). 5 reported Form 4/5 transactions since Sep 2024; latest on Oct 7, 2025. Located in LONDON, X0.
Companies Ullman Anders has filed insider reports for
- Verona Pharma plc (VRNA): Director
Ullman Anders
CIK: 0001836816
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)2 (40.0%)
Derivative conversions
Awards (A)1 (20.0%)
Compensation grants
Other (G, F, J, C, D, …)2 (40.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
VRNA
Verona Pharma plc
Director
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Oct 7, 2025VRNA
Verona Pharma plc
DispositionDirect358.9K shares- - Oct 7, 2025VRNA
Verona Pharma plc
ExerciseDirect72K shares- - Oct 7, 2025VRNA
Verona Pharma plc
DispositionDirect72K shares- - Aug 1, 2025VRNA
Verona Pharma plc
ExerciseDirect24K shares- - Apr 25, 2025VRNA
Verona Pharma plc
AwardDirectRestricted Share Units
96K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 7, 2025 | VRNA Verona Pharma plc | Disposition | 358,856 | - | - | Direct |
| Oct 7, 2025 | VRNA Verona Pharma plc | Exercise | 72,000 | - | - | Direct |
| Oct 7, 2025 | VRNA Verona Pharma plc | Disposition | 72,000 | - | - | Direct |
| Aug 1, 2025 | VRNA Verona Pharma plc | Exercise | 24,000 | - | - | Direct |
| Apr 25, 2025 | VRNA Verona Pharma plc | Award Restricted Share Units | 96,000 | - | - | Direct |
1-5 of 5 transactions